Forty Seven Competitors and Similar CompaniesClear all
Forty Seven's competitors and similar companies include Cleave Biosciences, Zymeworks, Coherus Oncology and Gossamer Bio.
 Forty Seven Forty Seven is an immuno-oncology company, which develops therapies that target cancer immune evasion pathways. |  Cleave Biosciences Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date 2014 | Founding Date 2010 | Founding Date 2003 | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Menlo Park, US HQ Mountain View, US Sacramento, US | Locations Burlingame, US HQ | Locations Vancouver, CA HQ Seattle, US | Locations Redwood City, US HQ Camarillo, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 62 | Employees 3 | Employees 45519% increase | Employees 14736% decrease | Employees 11820% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 85.6 m | Valuation ($) 208 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $15.7m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income ($87.6m) (FY, 2019) | Net income N/A | Net income ($81.1m) (FY, 2025) | Net income $168m (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 156m | Total funding raised $ 129m | Total funding raised $ 125.9m | Total funding raised $ 174.5m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Cleave Biosciences
HQ
Burlingame, US
Employees
3
Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company